UPCOMING SESSIONS in ET
Tue, Sep 1, 2026
5:00 – 6:00 AM Bangkok
Understanding Your Care Journey: From Testing to Treatment Brian L. Miller II Click Here To Register
UPCOMING SESSIONS in ET
Tue, Sep 1, 2026 · 5:00 – 6:00 AM Bangkok
Understanding Your Care Journey: From Testing to Treatment
Brian L. Miller II
Click Here To Register
View all sessions
Jul 07, 2026
Ugandans have been urged to know their sickle cell status and embrace early screening as the country strengthens efforts to combat sickle cell disease, one of the…
Jul 07, 2026
In developed countries, many people living with sickle cell disease routinely celebrate their 50th, 60th birthdays and beyond, enjoying good quality of life thanks…
Jul 07, 2026
The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for mitapivat in sickle cell disease (SCD).…
Jul 06, 2026
The Food and Drug Administration (FDA) has expanded the approval of Casgevy® (exagamglogene autotemcel) to include patients aged 2 years and older with either…
Jul 06, 2026
The FDA has granted supplemental approval to exagamglogene autotemcel (Casgevy; Vertex Pharmaceuticals) for patients 2 years and older with sickle cell disease (SCD…
Jul 06, 2026
El Sabah Children’s Hospital has recorded over 300 cases of sickle cell disease in two years without diagnostic facilities, according to the Executive Director, Dr…
Jul 05, 2026
The spleen is one of the first organs injured in sickle cell disease (SCD) [1]. Splenic impairment in SCD children can silently progress toward functional asplenia…
Jul 02, 2026
WASHINGTON — The Food and Drug Administration Wednesday granted supplemental approval for a breakthrough CRISPR gene therapy medication, making it the first…
Jul 01, 2026
AbstractBackground and objectivesSickle cell disease is a major haemoglobin disorder, and foetal haemoglobin (HbF) remains the strongest modifier of disease…
Jul 01, 2026
AbstractImportance: Suboptimal transitions from pediatric to adult health care can negatively impact disease outcomes, medication regimen adherence, and disease…